Leadership and Coordination Center (LACC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed)
ID: 358280Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $2K

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the Leadership and Coordination Center (LACC) to renew the MACS/WIHS Combined Cohort Study (MWCCS), focusing on the health and survival of middle-aged and older adults living with HIV in the United States. This six-year initiative, running from 2026 to 2032, aims to follow approximately 5,600 participants using a populomics approach to assess various health determinants, thereby enhancing clinical guidance, operational accountability, and community engagement across multiple study components. The LACC will play a crucial role in addressing health disparities related to HIV, particularly as aging populations face increasing comorbidities, with an estimated total program funding of $2 million available for this opportunity. Applications are due by May 2, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services is seeking applications for the Leadership and Coordination Center (LACC) to renew the MACS/WIHS Combined Cohort Study (MWCCS) that focuses on the health and survival of middle-aged and older adults living with HIV in the U.S. This six-year initiative (2026-2032) will follow approximately 5,700 participants, utilizing a populomics approach to assess diverse health determinants. The LACC is expected to enhance clinical guidance, operational accountability, and community engagement while overseeing a coordinated effort across multiple study components, including clinical research sites and data analysis centers. The funding opportunity emphasizes the importance of understanding health disparities in HIV, especially as aging populations are increasingly affected by comorbidities. The LACC will play an integral role in ensuring ethical conduct, participant wellbeing, and adherence to study protocols. The National Institutes of Health will allocate approximately $3 million, targeting research priorities that span cardiovascular, pulmonary, mental health, and the intersection of HIV with drug use and other chronic conditions. Applications are due by May 3, 2025, and must comply with rigorous submission guidelines to ensure thorough evaluation and funding efficacy.
    Similar Opportunities
    Limited Competition: Clinical Research Sites (CRS) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Notice of Funding Opportunity (NOFO) for the renewal of the MACS/WIHS Combined Cohort Study (MWCCS), aimed at funding up to 13 Clinical Research Sites (CRS) for a six-year period from 2026 to 2032. This initiative focuses on continuing research into the health determinants affecting middle-aged and older adults living with HIV, utilizing a populomics approach to address health disparities and improve quality of life for these populations. The funding opportunity is part of a broader NIH commitment to HIV research, with an anticipated investment of approximately $34.17 million, and applications are due by May 2, 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Limited Competition: Data Analysis and Sharing Center (DASC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Limited Competition: Data Analysis and Sharing Center (DASC) for the MACS/WIHS Combined Cohort Study (MWCCS), aimed at renewing a significant epidemiological study on HIV in the United States. This initiative seeks applications to fund a single DASC that will support the analysis and sharing of data from approximately 5,500 participants, focusing on the health determinants affecting people living with HIV (PLWH) and those without HIV (PLWOH) over a seven-year period from 2026 to 2033. The project emphasizes a populomics approach to investigate the multifaceted influences on health outcomes, integrating social, biological, and environmental factors, while adhering to strict data management protocols. The estimated total program funding is $2 million, with a close date for applications set for May 2, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Multidisciplinary Studies of HIV/AIDS and Aging," aimed at exploring the intersection of HIV and aging. This initiative seeks to enhance understanding of the biological, clinical, and socio-behavioral aspects of aging in the context of HIV infection, while also improving strategies for testing, prevention, and treatment of HIV-related health complications. Given the increasing number of older adults living with HIV, this research is crucial for addressing public health challenges and improving healthcare delivery across diverse populations. The funding supports exploratory research under the R21 mechanism, with a maximum budget of $275,000 for two years, and applications are due between May 2025 and January 2027. For more information, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-355.html.
    Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experiencing Health Disparities (R01 - Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experiencing Health Disparities." This initiative aims to support research that investigates the underlying mechanisms contributing to health disparities in HIV and aging, particularly focusing on how multiple comorbidities affect health outcomes and quality of life among individuals from marginalized populations. The program emphasizes a multidisciplinary approach and encourages engagement with community stakeholders to enhance the relevance of the research. Approximately $3 million is available for four awards and $1.5 million for two additional awards for fiscal year 2024, with a project duration of up to five years. Interested applicants can find more information and guidelines at the NIH Grants website and should direct inquiries to grantsinfo@nih.gov. The application deadline is set for January 7, 2026.
    Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)." This initiative aims to support multilevel and multidisciplinary intervention research focused on improving the quality of life and promoting successful aging among individuals living with HIV, particularly those from racial and ethnic minority groups and lower socioeconomic backgrounds. The funding, which ranges from $5-6 million to support approximately 5-6 awards, will provide a maximum budget of $750,000 annually over five years for projects that address social determinants of health and involve community engagement. Interested applicants can find more details and guidelines on the NIH website, with the application process opening on November 11, 2023, and a submission deadline of December 12, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)" aimed at enhancing research on the intersection of HIV and aging. The program seeks applications that focus on improving the understanding of biological, clinical, and socio-behavioral aspects of aging in the context of HIV infection, as well as developing better methods for testing, preventing, and managing HIV-related health issues among older populations. This initiative is particularly significant given the projected increase in the prevalence of HIV among older adults, which is expected to rise from 53% to over 70% by 2030, highlighting the urgent need to address the complex challenges associated with aging and HIV. Interested applicants can submit proposals until January 7, 2027, with no budget limits as long as they align with project needs; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-354.html.
    Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Multidisciplinary Studies of HIV/AIDS and Aging," inviting applications for research that explores the intersection of HIV and aging. The primary objectives of this grant are to enhance understanding of the biological, clinical, and socio-behavioral aspects of aging in individuals living with HIV, as well as to improve strategies for testing, preventing, and treating HIV and managing related health complications. This funding opportunity is significant for advancing health interventions for older adults affected by HIV, with eligible applicants including a wide range of institutions such as higher education entities, community organizations, and tribal governments. Interested parties should note that the application deadline is May 7, 2027, and can find further details and guidance by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-091.html.
    Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for multidisciplinary research on HIV/AIDS and aging through the R21 Exploratory/Developmental Research Grant program. This initiative invites applications that aim to enhance the understanding of the biological, clinical, and socio-behavioral aspects of aging in the context of HIV infection, with specific objectives to improve prevention, testing, treatment strategies, and management of HIV-related health issues in diverse populations, particularly older adults aged 70 and above. The grant provides funding of up to $275,000 for a two-year period, with key submission dates starting April 4, 2024, and a closing date for applications set for January 7, 2027. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders" through the R01 Research Project Grant. This initiative aims to support innovative and high-risk studies that explore the molecular mechanisms linking HIV and substance use disorders (SUDs), with a focus on advancing understanding of HIV dynamics within the Central Nervous System (CNS). The total estimated program funding is $2 million for fiscal year 2026, with the potential to support up to three awards, and applications must include clear milestones and human or primate studies. Interested applicants should note that the deadline for submitting letters of intent and applications is July 14, 2025, and no clinical trials are permitted under this grant. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for revision applications from currently funded Centers for AIDS Research (CFAR) and Developmental CFARs (D-CFAR) to enhance their support for outreach and research related to HIV and health disparities. The initiative aims to diversify and support the next generation of HIV/AIDS investigators by requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP), which will be a critical component of the application review process. This funding is vital for fostering innovative research and training programs that address key barriers in HIV research, particularly for underrepresented groups. The maximum award amount is $1.5 million annually, with applications due by October 9, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-080.html.